Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non–small cell lung cancer: A phase II study

2020102 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Thoracic and Cardiovascular Surgery

Volume 161, Issue 2, pp. 434-442.e2

Field-Weighted Citation Impact: 7.34